CRISPR/Cas9-mediated γ-globin expression upregulation in HEK293T cells

Objective To edit the γ-globin promoter of HEK293T cells using the CRISPR/Cas9 technology to upregulate γ-globin and explore the feasibility of using gene editing technology for the treatment of β-thalassemia. Methods Using gene editing technology to treat β-thalassemia, two sgRNA sequences were des...

Full description

Saved in:
Bibliographic Details
Main Authors: HUANG Xianjuan, LAI Yongrong, LI Jing
Format: Article
Language:zho
Published: Editorial Office of Journal of Guangxi Medical University 2025-04-01
Series:Guangxi Yike Daxue xuebao
Subjects:
Online Access:https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.02.011
Tags: Add Tag
No Tags, Be the first to tag this record!